Evaluation of a method of intracoelomic catheterization in koi

Journal of the American Veterinary Medical Association

Volumn 226, Issue 5, 2005, Pages 784-788

  Lewbart, Gregory A ^a   Butkus, Deborah A ^a   Papich, Mark G ^a   Coleman, Angela K ^a,b   Krum, Howard N ^a,c   Noga, Edward J ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

^c GEORGIA AQUARIUM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN; TRICAINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CATHETER; CATHETERIZATION; CONTROLLED STUDY; DRUG HALF LIFE; EVALUATION; FISH; NONHUMAN;

ANIMALS; CARPS; CATHETERIZATION; CATHETERS, INDWELLING; DRUG ADMINISTRATION ROUTES; FLUOROQUINOLONES; PROSPECTIVE STUDIES; QUINOLONES; SAFETY;

ANIMALIA; COPROSMA KAUENSIS;

EID: 14344265620     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.226.784     Document Type: Article

References (40)

1. Buttitta B. Aquatic medicine starting to make a splash. Veterinary Product News 1998;10:1, 38-39.
2. Kuehn BM. Veterinarians test the waters of fish medicine. J Am Vet Med Assoc 2002;221:1671-1672.
3. Lewbart GA. Pet fish medicine beckons to pioneer veterinarians. Veterinary Product News 1999;11:50-51.
4. Purchase HG, Gloyd J, Pitts JL. Opportunities for veterinarians in aquaculture. J Am Vet Med Assoc 1993;202:734-737.
5. Gerkhe C. Results of the AVMA survey of US pet-owning households on companion animal ownership. J Am Vet Med Assoc 1997;211:169-170.
6. Smith CA. Pet fish medicine offers new challenges. J Am Vet Med Assoc 1993;205:1267-1271.
7. Carpenter JW, Mashima TY, Rupiper DJ. Exotic animal formulary. 2nd ed. Philadelphia: WB Saunders Co, 2001.
8. Lewbart GA. CVT update: antibiotic treatment of aquarium fish. In: Bonagura J, ed. Current veterinary therapy XIII. Philadelphia: WB Saunders Co, 1999;1196-1198.
9. Stoskopf MK. Fish pharmacotherapeutics. In: Fowler ME, Miller RE, eds. Zoo & wild animal medicine: current therapy 4. Philadelphia: WB Saunders Co, 1999;182-189.
10. Wildgoose WH, Lewbart GA. Therapeutics. In: Wildgoose WH, ed. BSVA manual of ornamental fish. 2nd ed. Ames, Iowa: Blackwell Publishing Professional, 2001;237-258.
11. Lewbart GA, Harms CA. Building a fish anesthesia delivery system. Exotic DVM Magazine 1999;1:25-28.
12. Soivio A, Nyholm K, Westman K. A technique for repeated sampling of the blood of individual resting fish. J Exp Biol 1975;62:207-217.
13. Van Raaij MT, Vianen GJ, Van den Thillart GE. Blood gas parameters and the responses of erythrocytes in carp exposed to deep hypoxia and subsequent recovery. J Comp Physiol [B] 1996;166:453-460.
14. Brauner CJ, Wang T, Val AL, et al. Non-linear release of Bohr protons with haemoblobin-oxygenation in the blood of two teleost fishes: carp (Cyprinus carpio) and tambaqui (Colossoma macropomum). Fish Physiol Biochem 2001;24:97-104.
15. Skov PV, Steffensen JF. The blood volumes of the primary and secondary circulatory system in the Atlantic cod Gadus morhua L, using plasma bound Evans Blue and compartmental analysis. J Exp Biol 2003;206:591-599.
16. Deng DF, Refstie S, Hemre GI, et al. A new technique of feeding, repeated sampling of blood and continuous collection of urine in white sturgeon. Fish Physiol Biochem 2000;22:191-197.
17. Brill RW, Cousins KL, Jones DR, et al. Blood volume, plasma volume and circulation time in a high-energy-demand teleost, the yellowfin tuna (Thunnus albacares). J Exp Biol 1998;201:647-654.
18. Keen JE, Vianzon D, Farrell AP, et al. Thermal acclimation alters both adrenergic sensitivity and adrenoceptor density in cardiac tissue of rainbow trout. J Exp Biol 1993;181:27-47.
19. Bakal RS, Bai SA, Stoskopf MK. Pharmacokinetics of sulfadimethoxine and ormetoprim in a 5:1 ratio following intraperitoneal and oral administration, in the hybrid striped bass (Morone chrysops X Morone saxatilis). J Vet Pharmacol Ther 2004;27:1-6.
20. McGeer JC, Eddy FB. Effects of sodium nitroprusside on blood circulation, and acid-base, and ionic balance in rainbow trout: indications for nitric oxide induced vasodilation. Can J Zool 1996;74:1211-1219.
21. Bermingham EC, Papich MG. Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep. Am J Vet Res 2002;63:1012-1017.
22. Neer TM. Clinical pharmacologic features of fluoroquinolone antimicrobial drugs. J Am Vet Med Assoc 1988;193:577-580.
23. Vancutsem PM, Babish JG, Schwark WS. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet 1990;80:173-186.
24. Sheer M. Concentrations of active ingredient in the serum and in tissues after oral and parenteral administration of Baytril. Vet Med Rev 1987;2:104-118.
25. Walker RD, Stein GE, Hauptman JG, et al. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am J Vet Res 1989;53:2315-2319.
26. Flammer K, Aucoin DP, Whitt DA. Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses. J Vet Pharmacol Ther 1991;14:359-366.
27. Prezant RM, Isaza R, Jacobson ER. Plasma concentrations and disposition kinetics of enrofloxacin in gopher tortoises (Gopherus polyphemus). J Zoo Wildl Med 1994;25:82-87.
28. Young LA, Schumacher J, Papich MG, et al. Disposition of enrofloxacin and its metabolite ciprofloxacin after intramuscular injection in juvenile Burmese pythons (Python molurus bivittatus). J Zoo Wildl Med 1997;28:71-79.
29. Kaartinen L, Panu S, Pyorala S. Pharmacokinectis of enrofloxacin in horses after single intravenous and intramuscular administration. Equine Vet J 1997;29:378-381.
30. Bregante MA, Saez P, Aramayona JJ, et al. Comparative Pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows. Am J Vet Res 1999;60:1111-1116.
31. Linnehan RM, Ulrich RW, Ridgway S. Enrofloxacin serum bioactivity in bottlenose dolphins, Tursiops truncatus, following oral administration of 5 mg/kg in whole fish. J Vet Pharmacol Ther 1999;22:170-173.
32. Dalsgaard I, Bjerregaard J. Enrofloxacin as an antibiotic in fish. Acta Vet Scand Suppl 1991;87:300-302.
33. Barnes AC, Lewin CS, Hastings TS, et al. In vitro activities of 4-quinolones against the fish pathogen Aeromonas salmonicida. Antimicrob Agents Chemother 1990;34:1819-1820.
34. Martinsen B, Oppegaard H, Wichstrom R, et al. Temperature-dependent in vitro antimicrobial activity of four 4-quinolones and oxytetracycline against bacteria pathogenic to fish. Antimicrob Agents Chemother 1992;36:1738-1743.
35. Reimlinger M, Hoffman R, Pfeil-Putzien C, et al. Enrofloxacin, a new drug for ornamental fish. Tierartzliche Prax 1990;18:653-657.
36. Stoffregen DA, Chako AJ, Backman S, et al. Successful therapy of furunculosis in Atlantic salmon, Salmo salar, using the fluoroquinolone antimicrobial agent enrofloxacin. J Fish Dis 1993;16:219-228.
37. Bowser PR, Wooster GA, St Leger J, et al. Pharmacokinetics of enrofloxacin in fingerling rainbow trout (Oncorhynchus mykiss). J Vet Pharmacol Ther 1992;15:62-71.
38. Lewbart G, Vaden S, Deen J, et al. Pharmacokinetics of enrofloxacin in the red pacu (Colossoma brachypomum). J Vet Pharmacol Ther 1997;20:124-128.
39. Stoffregen DA, Wooster GA, Bustos PS. Multiple route and dose pharmacokinetics of enrofloxacin in juvenile Atlantic salmon. J Vet Pharmacol Ther 1997;20:111-123.
40. Bowser PR, House M. In vitro sensitivity of some fish pathogens to the quinolones naladixic acid and oxolinic acid and the fluoroquinolone enrofloxacin. Bull Eur Assoc Fish Pathol 1990;10:48-49.